Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2318
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin ; volume:22 ; number:1 ; day:3 ; month:2 ; year:2022 ; pages:1-10 ; date:12.2022
BMC geriatrics ; 22, Heft 1 (3.2.2022), 1-10, 12.2022
- Urheber
-
DeCarlo, Kristen
Wallia, Amisha
Kang, Raymond H.
Cooper, Andrew
Cherupally, Manisha
Harris, Sterling A.
Aikman, Cassandra
Liss, David T.
Ackermann, Ronald T.
O’Brien, Matthew J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12877-022-02792-3
- URN
-
urn:nbn:de:101:1-2022051222564181627184
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- DeCarlo, Kristen
- Wallia, Amisha
- Kang, Raymond H.
- Cooper, Andrew
- Cherupally, Manisha
- Harris, Sterling A.
- Aikman, Cassandra
- Liss, David T.
- Ackermann, Ronald T.
- O’Brien, Matthew J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metformin, the remarkable and unique antidiabetic agent
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Initiating Antidepressant Medication: What is the Most Important Factor?
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
Ecotoxicological assessment of metformin as an antidiabetic water residue treated by electron beam accelerator irradiation
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
Metformin, the remarkable and unique antidiabetic agent
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Initiating Antidepressant Medication: What is the Most Important Factor?
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
Ecotoxicological assessment of metformin as an antidiabetic water residue treated by electron beam accelerator irradiation
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
Metformin, the remarkable and unique antidiabetic agent
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa
Initiating Antidepressant Medication: What is the Most Important Factor?
Medication beliefs in first-line and second-line treated multiple sclerosis patients
Congenital tuberculosis (TB) use of second-line medication and therapeutic drug monitoring
Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
Ecotoxicological assessment of metformin as an antidiabetic water residue treated by electron beam accelerator irradiation
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons